Table 2.
Day 3 | |||||
---|---|---|---|---|---|
TCPS | PEU | SR | PET | ||
IL-2 (pg/mL) | Experimental | 11 | 16 | 6 | 5 |
PHA Control | 195 ± 100 | 291 ± 120 | 326 ± 150 | 334 ± 127 | |
IFNγ (pg/mL) | Experimental | 49 | 18 | 191 | 168 |
PHA Control | 6610 ± 2430 | 7260 ± 2160 | 6680 ± 2640 | 7590 ± 2740 |
Day 7 | |||||
---|---|---|---|---|---|
TCPS | PEU | SR | PET | ||
IL-2 (pg/mL) | Experimental | 1 | 3 | 4 | 1 |
PHA Control | 3.8 ± 0.4 | 7.1 ± 0.7 | 6.6 ± 5.0 | 8.8 ± 2.8 | |
IFNγ (pg/mL) | Experimental | 12 | 411 | 148 | 77 |
PHA Control | 8100 ± 2470 | 8700 ± 3000 | 8430 ± 2620 | 8570 ± 2850 |
Data from experimental group represent values from one donor (concentrations of IL-2 and IFNγ were not detectable in all other donors). Data from PHA controls represent data from cultures stimulated with 2% PHA from 3 donors.